Gobarden Injection, Solution
Product Images NDC 83831-176

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Gobarden (NDC 83831-176). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (D2d3080a 6cef 4a91 8035 6fd8b41109e6 01)

Chemical structure of Bendamustine Hydrochloride, showing its molecular arrangement with chlorine atoms, nitrogen atoms in the heterocyclic ring, and a carboxyl group.*

FDA Label Image

Figure 1 (D2d3080a 6cef 4a91 8035 6fd8b41109e6 02)

A Kaplan-Meier survival curve graph showing progression-free survival (months) comparing Bendamustine Hydrochloride and Chlorambucil treatment groups. The y-axis represents the survival distribution function, while the x-axis represents time in months, illustrating survival differences between the two study treatments over approximately 45 months.*

FDA Label Image

Gobarden (bendamustine Hydrochloride Injection), 100 mg/4 mL (Container Label)

GOBARDEN 100 mg/4 mL (25 mg/mL) injection label showing it as a bendamustine hydrochloride solution for intravenous infusion. The label states it is a sterile 4 mL multiple-dose vial, with instructions to dilute the dose in a 500 mL admixture before administration. It notes storage conditions, manufacturer AVYXA Pharma, LLC, and includes warnings, dosage references, and a barcode.*

FDA Label Image

Gobarden (bendamustine Hydrochloride Injection), 100 mg/4 mL (Carton Label)

Carton label for Gobarden (bendamustine hydrochloride injection) 100 mg/4 mL (25 mg/mL) intravenous solution. The label shows product name, strength, dosage form, NDC 83831-176-04, and a warning that dilution is required in sodium chloride or dextrose infusion prior to administration. Manufactured for AVYXA Pharma, LLC, made in India, with barcode and storage instructions visible. The label also includes an inactive ingredient list and branding elements.*

FDA Label Image

Image (E158fe02 38b0 44cd 9352 0a43cd9be96f 107 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.